High fear of cancer recurrence (FCR) impacts patient's quality of life (QoL) and is prevalent among patients with familial melanoma. The main objective is to investigate whether EMDR is effective in treating high FCR in patients with familial melanoma. The study design is a non-blinded, randomized waiting-list controlled trial. Patients aged 18 years or older with familial melanoma can be included. Patients with high FCR will receive a maximum of 4, 90 minutes, EMDR-sessions. The main study parameter is the decrease and level of FCR measured with the Cancer Worry Scale (CWS). The secondary study parameter is quality of life, measured with the EORTC.
a score of 16 or higher on the FCRI-NL-SF
18 years or older
diagnosed with familial melanoma
insufficient knowledge of the Dutch language.
acute psychiatric disease (psychosis, suicidal ideation)
variable dosis of anxiolytics
Leiden University Medical Center
Lead sponsor
Erasmus Medical Center
Collaborator